ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,035, issued on Aug. 5, was assigned to AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO-A.C.R.A.F. S.p.A. (Rome).

"Peptides for inhibiting cholinergic calcitonin gene-related peptide (CGRP) and acetylcholine (ACH) release or inhibiting sensitization-mediated by TRPV1-mediated excitability in sensory neurons and methods of use thereof" was invented by Francesca Mancini (Nettuno, Italy), Isabel Devesa Giner (Elche, Spain), Antonio Ferrer Montiel (Alicante, Spain), Gregorio Fernandez Ballester (Murcia, Spain), Giorgina Mangano (Rome) and Cristina Bartella (Rome).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to peptides capable of inhibi...